Several studies have shown that the PI3K/AKT SHIP1 phosphatase is a key target of miR-155 in AML cells: the targeting of SHIP1 by miR-155 results in a spontaneous activation of the PI3K/AKT signaling pathway in leukemic cells [97]. This evidence concerns the gene INPP5D and acute myeloid leukemia.